Robuta

https://www.sciencedaily.com/releases/2014/06/140626141019.htm
Surgical biopsies can be safely performed on select patients with late-stage non-small cell lung cancer, which should enhance their access to drugs that target...
late stagelung cancersurgicalbiopsyproves
https://www.healthday.com/health-news/cancer/cheap-health-insurance-can-delay-cancer-diagnosis-increase-risk-of-death
Discover how short-term health insurance plans can delay cancer diagnosis and increase the risk of death, according to a new study by the American Cancer...
late stage cancershort termhealth plansincreasediagnoses
https://www.purdue.edu/newsroom/archive/releases/2015/Q1/drug-combo-suppresses-growth-of-late-stage-prostate-cancer-tumors.html
Low doses of metformin, a widely used diabetes medication, and a gene inhibitor known as BI2536 can successfully halt the growth of late-stage prostate cancer...
late stageprostate cancerdrugcombosuppresses
https://www.healthywomen.org/condition/why-is-late-stage-cervical-cancer-on-the-rise
Rates of cervical cancer have dropped significantly in the past 50 years, but a recent uptick in diagnoses has experts concerned
late stagecervical cancerrisehealthywomen
https://www.fox13now.com/news/health/late-stage-cervical-cancer-cases-are-on-the-rise
Most cervical cancer cases can be prevented, and most other cases can be treated effectively if caught early. But as the number of cases decline, the number of...
late stagecervical cancercasesrise
https://endpoints.news/roches-oral-serd-delays-early-breast-cancer-recurrence-in-late-stage-trial/
Nov 18, 2025 - Roche's breast cancer pill giredestrant beats standard care post-surgery in Phase 3 trial, showing significant survival benefit. AstraZeneca's similar drug...
early breast canceroralserddelaysrecurrence
https://www.biospace.com/anti-cancer-compound-in-vegetables-found-to-block-late-stage-breast-cancer-cell-growth
anti cancerlate stagecompoundvegetablesfound
https://www.biopharmadive.com/news/abbvies-parp-inhibitor-fails-two-late-stage-cancer-trials/440902/
Veliparib did not meet primary endpoints in studies testing it as a treatment for lung and breast cancer.
late stage cancerparp inhibitorabbviefailstwo